ADAM STONE
Profile
First Name
: ADAM
Middle Name
:
Last Name
: STONE
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
DIRECTOR
ALVARO AMORRORTU, MATTHEW ARNOLD, ALEXANDER (BO) CUMBO, STEPHEN DIPALMA, MARTIN FREED, ILAN GANOT, JESSIE HANRAHAN, PAUL HERIZCH, LYNETTE HERSCHA, DAVID TYRONNE HOWTON, ROBERT HUFFINES, CLARE KAHN, GEORGIA KERESTY, ADAM KOPPEL, JENNIFER MARLOWE, CARL MORRIS, SUKUMAR NAGENDRAN, JORGE A. QUIROZ, JOEL SCHNEIDER, RAJEEV SHAH, IAN SMITH, LYNNE SULLIVAN, ANDREY ZARUR, JENNIFER ZIOLKOWSKI
DIRECTOR
GREGORY BEHAR, ROLF J. BENIRSCHKE, THIERRY DERVIEUX, PHARM D., PH.D., JOY GHOSH, PH.D., SCOTT L. GLENN, MARTIN HENDRIX, PH.D., LAURENS KRUIDENIER, PH.D., JAMES LAUR, JAMES D. LAUR, ALLISON LUO, M.D., KEITH W. MARSHALL, PH.D., MARK MCKENNA, SHLOMO MELMED, LAUREN OTSUKI, LAUREN G. OTSUKI, JOSEPH C. PAPA, GERALD T. PROEHL, WILLIAM SANDBORN, M.D., CHRIS SLAVINSKY, MARK STENHOUSE, STEPHAN TARGAN, DOUGLAS WALL, DOUGLAS F. WALL, MIKE WALTHER, SHIERLEY WIDJAJA, TADATAKA YAMADA, TADATAKA YAMADA, M.D., TADATAKA TACHI YAMADA, M.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-12-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-10-30
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-10-22
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-07-30
